Immunological outcomes after six months with first line antiretroviral therapy: a lesson from Yogyakarta, Indonesia | Zendy

Mardy Pangarungan | Zendy; Eggi Arguni | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Immunological outcomes after six months with first line antiretroviral therapy: a lesson from Yogyakarta, Indonesia

Author(s) -

Mardy Pangarungan,

Eggi Arguni

Publication year - 2018

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.9743

Subject(s) - medicine , antiretroviral therapy , incidence (geometry) , tuberculosis , human immunodeficiency virus (hiv) , pediatrics , medical record , retrospective cohort study , viral load , immunology , pathology , physics , optics

More than 1,300 children aged 0-14 years were infected with HIV in Indonesia by 2016. Adequate antiretroviral therapy (ART) can increase nutritional and immunological status, reduce incidence of opportunistic infection and mortality caused by HIV infection. After ART initiation, the children's treatment response needs to be monitored with CD4+ cell count and Viral Load (VL) evaluation. In resource-limited setting, clinical and immunological parameters can be used to evaluate ART outcomes. The aimed of this study to know immunological status of the patient after 6 months ART in Dr. Sardjito Hospital in Yogyakarta, Indonesia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research